Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating a frontend update. No study data or content has changed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe footer now shows Revision: v3.5.4, updating the site version reference. This reflects a new build of the page template and does not alter study data or visible content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page footer revision label was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site release.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedStudy Record Dates were updated with new update entries (2026-04-02, 2026-04-01, 2026-03) and removal of older entries (2026-02-02, 2026-01-30, 2026-01).SummaryDifference0.2%

- Check82 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.